CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY

Aim. To study the clinical and laboratory characteristics of patients with stable angina that are sensitive or resistant to acetylsalicylic acid (ASA) before and after coronary artery bypass graft (CABG) surgery. Material and methods. Patients (n=60) with stable angina III-IV functional class, undergoing CABG, were included into the study. In the first postoperative day all patients started to take ASA in enteric form at a dose of 100 mg. To determine the sensitivity to ASA platelet aggregation induced by adenosine diphosphate (ADP 5μM) and arachidonic acid (1 mM) before and after incubation with ASA in vitro was studied one day before CABG and at the 1st and 10th days after CABG using an optical aggregometer. Dielectric properties of blood and its components were also studied with the original Fourier spectrometer. Results. The ASA-resistance rate was 26.7%. The ASA-resistant patients as compared with ASA-sensitive patients more often received selective cyclooxygenase 2 (COX-2) inhibitors (44% vs. 17%, respectively, p<0.05) after CABG. They had higher serum creatinine levels at the 1st day after CABG (153.7±49.9mmol/L vs 115.3±29mmol/L, respectively, p=0.028), >and very high erythrocyte sedimentation rate at 10th day after CABG (80.625±21.3 mm/h vs 54.6±26.5 mm/h; respectively, p=0.028). 33% of patients had resistance to en-teric form of ASA during 10-day therapy after CABG, however, platelet aggregation induced by arachidonic acid was low in in vitro platelet incubation with ASA. This points at decreased bioavailability of enteric forms of ASA. “Transient” ASA-resistance was detected in 12.5% of ASA-resistant patients on the 1st day after CABG due to cardiopulmonary bypass. Significant differences in the dielectric characteristics of blood and platelets were found in the groups of ASA-resistant and ASA-sensitive patients 10 days after CABG. Conclusion. Cardiopulmonary bypass, COX-2 inhibitors, renal dysfunction, the inflammatory response, may be possible reasons of the ASA-resistance after CABG. Changes in dielectric parameters of blood and platelets were found in the ASA-resistant patients.

1. Gasevic D, Khan NA, Qian H, et al. Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and white patients with acute myocardial infarction: administrative data analysis. BMC Cardiovascular Disorders 2013; 13: 121.

2. Nathoe H. M., van Dijk D., Jansen E. W., et al. Cardiac outcome and cost-effectiveness one year after off-pump and on-pump coronary artery bypass surgery: Results from a randomized study // Journal of the American College of Cardiology 2003; 41(6): 380A.

3. Aradi D, Komócsi A, Vorobcsuk A, et al. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Am Heart J 2010; 160(3): 543-51.

4. Poston R., Gu J. Y., Manchio J., et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. European Journal of Cardio-Thoracic Surgery 2005: 27(4): 584-90.

5. Liu X.-F., Cao J., Fan L., et al. Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease. Journal of Geriatric Cardiology 2013; 10(1): 21-7.

6. Ulehlova J, Slavik L, Krcova V, et al. The assessment of aspirin resistance by using light transmission and multiple electrode aggregometrу. Int J Lab Hematol 2011; 33(3): 305-9.

7. Grinshtein YI, Savchenko AA, Grinshtein IY, et al. Features of hemostasis, platelet metabolic activity and the frequency of aspirin resistance in patients with chronic heart failure after coronary artery bypass grafting. Kardiologiia 2008; 6: 51-6. In Russian (Особенности гемостаза, метаболической активности тромбоцитов и частота резистентности к аспирину у больных с хронической сердечной не-достаточностью после аортокоронарного шунтирования. Кардиология 2008; 6: 51-6).

8. Grinshtein YI, Kosinova AA, Grinshtein IY. Antiplatelet therapy monitoring: a crisis of confidence or a search for new solutions. Rational Pharmacotherapy in Cardiology 2013; 6: 668-75. In Russian (Гринштейн Ю.И., Косинова А.А., Гринштейн И.Ю. Контроль антитромбоцитарной терапии: кризис доверия или поиск новых решений? Рациональная фармакотерапия в кардиологии 2013; (6): 668-75).

9. Baker M. J., Trevisan J., Bassan P., et al. Using Fourier transform IR spectroscopy to analyze biological materials. Nature Protocols 2014; 9(8):1771-91.

10. Cole KS. Theoretical and Mathematical Biology. The nerve impulse (theory and experiment). Moscow: Mir; 1968. In Russian (Коул К. С. Теоретическая и математическая биология. Нервный импульс (теория и эксперимент). М: Мир; 1968).

11. Modica A, Karlsson F, Mooe T. Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection. J Thromb Haemost 2007; 5: 507-11.

12. Grosser T, Fries S, Lawson J, et al. Drug Resistance and Pseudoresistance An Unintended Consequence of Enteric Coating Aspirin. Circulation 2013; 127(3): 377-85.

13. Vykoukal D. M., Gascoyne P. R. C., Vykoukal J. Dielectric characterization of complete mononuclear and polymorphonuclear blood cell subpopulations for label-free discrimination. Integrative Biology 2009;1(7):477-84.

14. Collet J.-P., Cuisset T., Range G., et al. Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting. New England Journal of Medicine 2012; 367(22): 2100-9.

15. Wang Z., Gao F., Men J., et al. Aspirin resistance in off-pump coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery 2012; 41(1): 108-12.

16. Group A. R. Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT). PLoS clinical trials 2006; 1(7): e33.

17. Blann A. D., Kuzniatsova N., Velu S., et al. Renal function and aspirin resistance in patients with coronary artery disease. Thrombosis Research 2012: 130(3): Е103-6.